Contact this trialFirst, we need to learn more about you.
Checkpoint Inhibitor
Sonidegib + Pembrolizumab for Advanced Cancers
Recruiting3 awardsPhase 1
Rochester, Minnesota
This trial is testing the best dose of sonidegib in combination with pembrolizumab to treat patients with advanced solid tumors. Sonidegib may stop tumor growth by blocking enzymes needed for cell growth. Pembrolizumab may help the body's immune system attack the cancer and prevent tumor cells from growing and spreading. Giving sonidegib and pembrolizumab may work better than standard treatment.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.